Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

TSX:CSCI - Post Discussion

COSCIENS Biopharma Inc > Adult trial failed to meet primary endpoint but was approved
View:
Post by fossi_2002 on Aug 27, 2024 11:50am

Adult trial failed to meet primary endpoint but was approved

Proph... is grasping at the last straw. Everything is useless. Further losses loom and the listing on the NASDAQ is a distant prospect. In order for Gilles to achieve his goal, he will consider another share consolidation.
We - Oats and Ciao and all other shareholders - should all pull together to ensure that the Gilles era ends as soon as possible.


Comment by prophetoffactz on Aug 27, 2024 12:27pm
fossi, why not provide your analysis for how the other tests concluded the patients were growth hormone deficient yet macimorelin showed the same patients could produce growth hormone? This is a very interesting result. Are the other tests overdiagnosing growth hormone deficiency and leading to the overtreatment of children with unnessessary drug? Do you support that? Does the industry have a ...more  
Comment by Hopeforthebest on Aug 27, 2024 4:32pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities